@prefix jvr: . @prefix skos: . @prefix mesh: . @prefix owl: . @prefix dc: . @prefix xsd: . jvr:-H331X35G-9 skos:prefLabel "(Pyridin-2-ylméthyl)sulfinyl-1H-benzimidazoles"@fr, "2-Pyridinylmethylsulfinylbenzimidazoles"@en ; a mesh:Descriptor, skos:Concept ; skos:narrower jvr:-J6LRQX7B-C . jvr:-BT300B3G-Q skos:prefLabel "cerebrospinal fluid (Qualifier)"@en, "liquide cérébrospinal (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-WZ6QVBVC-P skos:prefLabel "Dexlansoprazole"@fr, "Dexlansoprazole"@en ; a mesh:Descriptor, skos:Concept ; skos:broader jvr:-J6LRQX7B-C . jvr:-L6C0XPHT-4 skos:prefLabel "métabolisme (Qualificatif)"@fr, "metabolism (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-XV06LPML-W skos:prefLabel "urine (Qualifier)"@en, "urine (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-Q3979798-W skos:prefLabel "analysis (Qualifier)"@en, "analyse (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-H7K65Q8S-Z skos:prefLabel "radiation effects (Qualifier)"@en, "effets des radiations (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-TJHVZCRZ-0 skos:prefLabel "administration et posologie (Qualificatif)"@fr, "administration & dosage (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-G30ZJ446-J skos:prefLabel "toxicity (Qualifier)"@en, "toxicité (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-NFTHND7Q-8 skos:prefLabel "intoxication (Qualificatif)"@fr, "poisoning (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-FWD2BGQ0-9 skos:prefLabel "usage thérapeutique (Qualificatif)"@fr, "therapeutic use (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-THHNVC7V-3 skos:prefLabel "synthèse chimique (Qualificatif)"@fr, "chemical synthesis (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-R0ZCQ8X6-J skos:prefLabel "agonistes (Qualificatif)"@fr, "agonists (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-S0CS1X5R-5 skos:prefLabel "immunology (Qualifier)"@en, "immunologie (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-M63HSDM7-1 skos:prefLabel "antagonists & inhibitors (Qualifier)"@en, "antagonistes et inhibiteurs (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-HQRFT0C6-B skos:prefLabel "isolement et purification (Qualificatif)"@fr, "isolation & purification (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-NB0XHT3S-N skos:prefLabel "adverse effects (Qualifier)"@en, "effets indésirables (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-W6SQV79N-S skos:prefLabel "classification (Qualifier)"@en, "classification (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-CB30NGKB-3 skos:prefLabel "economics (Qualifier)"@en, "économie (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-G4R176S9-J skos:prefLabel "analogs & derivatives (Qualifier)"@en, "analogues et dérivés (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr: a skos:ConceptScheme . jvr:-SBNWSM1T-R skos:prefLabel "history (Qualifier)"@en, "histoire (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-LD3NXJ47-1 skos:prefLabel "Anti-Ulcer Agents"@en, "Antiulcéreux"@fr ; a mesh:Descriptor, skos:Concept . jvr:-D0F21513-5 skos:prefLabel "chemistry (Qualifier)"@en, "composition chimique (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-R3QWLHRG-V skos:prefLabel "standards (Qualifier)"@en, "normes (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-NHL3D2X0-S skos:prefLabel "sang (Qualificatif)"@fr, "blood (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-T9HQD7ST-J skos:prefLabel "ressources et distribution (Qualificatif)"@fr, "supply & distribution (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-J6LRQX7B-C skos:hiddenLabel "Pro Ulco"@en, "Lansol"@en, "Ogast"@en, "AG 1749"@en, "Takepron"@en, "Lanzor"@en, "Agopton"@en, "Ogastro"@en, "AG-1749"@fr, "Zoton"@en, "AG-1749"@en, "Lansoprazole sodique"@fr, "Ulpax"@en, "Opiren"@en, "Promeco"@en, "AG1749"@fr, "Bamalite"@en, "Lansoprazole de sodium"@fr, "Prezal"@en, "Monolitum"@en, "Lansoprazole Sodium"@en, "Prevacid"@en ; mesh:allowableQualifier jvr:-THHNVC7V-3, jvr:-NB0XHT3S-N, jvr:-L6C0XPHT-4, jvr:-M63HSDM7-1, jvr:-CB30NGKB-3, jvr:-W6SQV79N-S, jvr:-WK5F724J-1, jvr:-Q3979798-W, jvr:-HQRFT0C6-B, jvr:-G4R176S9-J, jvr:-FWD2BGQ0-9, jvr:-D0F21513-5, jvr:-R3QWLHRG-V, jvr:-NFTHND7Q-8, jvr:-NHL3D2X0-S, jvr:-XV06LPML-W, jvr:-NKM836P1-M, jvr:-S0CS1X5R-5, jvr:-G30ZJ446-J, jvr:-SBNWSM1T-R, jvr:-BT300B3G-Q, jvr:-T9HQD7ST-J, jvr:-TJHVZCRZ-0, jvr:-H7K65Q8S-Z, jvr:-R0ZCQ8X6-J ; a skos:Concept, mesh:Descriptor ; skos:narrower jvr:-WZ6QVBVC-P ; owl:sameAs ; mesh:pharmacologicalAction jvr:-G4JQ2Z44-D, jvr:-LD3NXJ47-1 ; skos:prefLabel "Lansoprazole"@en, "Lansoprazole"@fr ; skos:altLabel "Lansoprazol"@en, "0K5C5T2QPG"@fr, "0K5C5T2QPG"@en, "Lansoprazoles"@en, "GV9NY1U369"@fr, "GV9NY1U369"@en, "2-(((3-Methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl)methyl)sulfinyl)benzimidazole"@en ; skos:inScheme jvr: ; dc:created "2013-07-08"^^xsd:date ; skos:definition "A 2,2,2-trifluoroethoxypyridyl derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS. Lansoprazole is a racemic mixture of (R)- and (S)-isomers."@en ; skos:broader jvr:-H331X35G-9 ; dc:modified "2017-01-17"^^xsd:date ; dc:established "2014-01-01"^^xsd:date . jvr:-NKM836P1-M skos:prefLabel "pharmacology (Qualifier)"@en, "pharmacologie (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-WK5F724J-1 skos:prefLabel "pharmacokinetics (Qualifier)"@en, "pharmacocinétique (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-G4JQ2Z44-D skos:prefLabel "Inhibiteurs de la pompe à protons"@fr, "Proton Pump Inhibitors"@en ; a mesh:Descriptor, skos:Concept .